Reading the evidence
Magnesium and sleep
What a newer trial can tell us, and what it cannot
A supplement headline can sound more decisive than the evidence behind it. Magnesium is a useful example: a 2025 trial found a modest benefit, not a cure for insomnia. [1] This guide explains how to read that result without turning it into a product recommendation.
What the 2025 trial found
Researchers randomized 155 generally healthy adults aged 18–65 with poor sleep to magnesium bisglycinate or placebo for four weeks. The daily preparation supplied 250 mg elemental magnesium and 1,523 mg glycine as the bisglycinate compound, not a separate glycine supplement. This is a study description, not dose advice. [1]
Insomnia Severity Index scores improved by 3.9 points with the preparation versus 2.3 with placebo: an additional 1.6 points, small effect size 0.2, p = 0.049. Secondary outcomes did not differ significantly. [1]
The comparison cannot separate magnesium’s contribution from glycine’s. The trial relied on questionnaires, not objective sleep measurements. It establishes neither long-term benefit nor superiority to other formulations or effectiveness for all chronic insomnia. The university institute funded it; one author disclosed nutraceutical research and speaking relationships. These merit transparency, not automatic dismissal. [1]
Better than placebo is not the same as a large benefit
The fair question is not simply whether people improved after taking something. It is whether they improved more than people receiving the comparison treatment, and by enough to matter in daily life.
A p value does not tell you the probability that a supplement will help you. Nor does statistical significance establish that a change is important to every patient. Look for the size of the difference, how precisely it was estimated, what was measured and whether other studies agree. A person’s experience matters, but an individual before-and-after story cannot isolate the effect of a supplement.
How it fits the wider evidence
A 2021 systematic review found only three magnesium trials involving 151 older adults. The evidence was rated low or very low quality, with concerns about bias. A pooled estimate suggested faster sleep onset, but the total-sleep-time result was not statistically significant. That is a reason for further research, not a dependable promise about how many minutes someone will gain. [2]
The review also illustrates why a familiar, inexpensive nutrient still needs careful testing. Different populations, formulations and measurements make simple comparisons difficult. Combining several small studies does not remove weaknesses in their original design. [2]
Safety comes before experimenting
Magnesium supplements can cause diarrhea, nausea and abdominal cramps. Kidney impairment increases the risk of magnesium building up to harmful levels. Ask a clinician before using it if you have kidney disease, and ask a pharmacist about interactions, especially with certain antibiotics and oral osteoporosis medicines. [3]
The U.S. adult upper limit is 350 mg daily from supplements and medicines, not magnesium naturally present in foods. It is a safety limit, not a sleep-treatment target; individual medical circumstances can require a different plan. Count overlapping products, including antacids and laxatives. The Supplement Facts panel lists elemental magnesium rather than the weight of the entire compound. [3]
Foods such as beans, nuts, seeds and whole grains contribute magnesium. Meeting nutritional needs and treating an established deficiency are different questions from using a supplement to treat insomnia. Poor sleep alone does not diagnose a deficiency. [3]
Keep effective insomnia care in view
For chronic insomnia, the American Academy of Sleep Medicine strongly recommends multicomponent cognitive behavioral therapy for insomnia, or CBT-I. It works with sleep-related behaviors and thoughts; it is more than a list of sleep-hygiene tips. The guideline does not support sleep hygiene alone as a stand-alone treatment. [4]
If sleep problems persist or interfere with daytime life, seek an assessment rather than repeatedly changing supplements. A magnesium experiment should not delay discussion of evidence-based treatment or other possible causes of disturbed sleep.
Start with MySleepCure’s What is insomnia and CBT-I in depth resources. Use Sleep Tools as supporting education, not as a substitute for diagnosis or individualized care. Links are below.
Questions to bring to an appointment
- Is there a reason to suspect low magnesium in my case?
- Could a supplement interact with my medicines or other products?
- Would assessment or CBT-I be a more useful next step?
- If a supervised trial is appropriate, what outcome and stopping point would we agree on?
Bottom line: Read the comparison, not just the headline. A small research signal deserves interest without becoming a guarantee, a preferred-brand claim or a reason to postpone effective care.
Sources and related reading
1. Schuster J and colleagues. Magnesium bisglycinate supplementation in healthy adults reporting poor sleep. Nature and Science of Sleep, 2025.
2. Mah J and Pitre T. Oral magnesium supplementation for insomnia in older adults. BMC Complementary Medicine and Therapies, 2021; corrected 2024.
3. NIH Office of Dietary Supplements. Magnesium fact sheet for health professionals.
4. Edinger JD and colleagues. AASM behavioral and psychological treatments for chronic insomnia guideline, 2021.